Does TILDRAKIZUMAB-ASMN Cause Drug ineffective? 223 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 223 reports of Drug ineffective have been filed in association with TILDRAKIZUMAB-ASMN. This represents 13.8% of all adverse event reports for TILDRAKIZUMAB-ASMN.
223
Reports of Drug ineffective with TILDRAKIZUMAB-ASMN
13.8%
of all TILDRAKIZUMAB-ASMN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Drug ineffective From TILDRAKIZUMAB-ASMN?
Of the 223 reports, 2 (0.9%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Drug ineffective Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TILDRAKIZUMAB-ASMN. However, 223 reports have been filed with the FAERS database.
What Other Side Effects Does TILDRAKIZUMAB-ASMN Cause?
Product dose omission issue (363)
Psoriasis (86)
Death (84)
Product storage error (74)
Self-medication (74)
Off label use (66)
Condition aggravated (63)
Rash (54)
Pruritus (52)
Therapy cessation (50)
What Other Drugs Cause Drug ineffective?
ADALIMUMAB (71,926)
METHOTREXATE (70,142)
ETANERCEPT (60,367)
ADAPALENE (52,181)
ABATACEPT (35,212)
INFLIXIMAB (33,738)
TOCILIZUMAB (32,342)
RITUXIMAB (32,186)
LEFLUNOMIDE (31,396)
HYDROXYCHLOROQUINE (31,057)
Which TILDRAKIZUMAB-ASMN Alternatives Have Lower Drug ineffective Risk?
TILDRAKIZUMAB-ASMN vs TILIDINE
TILDRAKIZUMAB-ASMN vs TIMOLOL
TILDRAKIZUMAB-ASMN vs TIMOLOL\TRAVOPROST
TILDRAKIZUMAB-ASMN vs TINIDAZOLE
TILDRAKIZUMAB-ASMN vs TINZAPARIN